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Research in bacterial population genetics has increased in the last 10 years. Population
genetic theory and tools and related strategies have been used to investigate bacterial
pathogens that have contributed to recent episodes of temporal variation in disease fre-
quency and severity. A common theme demonstrated by these analyses is that distinct
bacterial clones are responsible for disease outbreaks and increases in infection frequency.
Many of these clones are characterized by unique combinations of virulence genes or alleles
of virulence genes. Because substantial interclonal variance exists in relative virulence,
molecular population genetic studies have led to the concept that the unit of bacterial
pathogenicity is the clone or cell line. Continued new insights into host–parasite interactions
at the molecular level will be achieved by combining clonal analysis of bacterial pathogens
with large-scale comparative sequencing of virulence genes.
To avert the threat of resurgent and new micro-
bial diseases, it is critical to gain insight into the
molecular mechanisms contributing to temporal
variation in disease frequency and severity. Al-
though comprehensive, unambiguous under-
standing of the host and parasite factors
mediating these processes is not available for any
infectious agent, population genetic research in
the last 10 years has provided noteworthy new
information about the bacterial side of the equa-
tion. This review will summarize the insights ac-
crued from population genetic analysis of bacteria
responsible for disease outbreaks or increases in
infection frequency and severity. One of the pri-
mary themes emerging from this research is that
distinct bacterial clones have been responsible for
several infection outbreaks (Table 1). Moreover,
the distinct clones are frequently characterized by
unique combinations of virulence genes or alleles
of virulence genes. These observations have im-
portant implications for our understanding of in-
fectious diseases and the public health measures
required to reduce their detrimental and poten-
tially devastating effect on society.
Population Genetics and Clonal Analysis of
Bacterial Pathogens: Basic Concepts
Population genetic study of bacterial pathogens
arose largely as an offshoot of research designed
to address questions of longstanding interest to
students of the molecular evolutionary processes
in higher eukaryotic organisms. Bacteria were an
attractive group of experimental organisms be-
cause of their phenotypic diversity, short genera-
tion times, haploid chromosomal genomes, and
accessory genetic elements. Hence, bacterial
population genetic research was originated by
population geneticists interested in bacteria,
rather than bacterial geneticists or medical micro-
biologists interested in population genetics (1, 2).
In spite of its important implications for how the
field has developed over the last decade, this on-
togeny will not be discussed in detail here. How-
ever, the reader should recognize that bacterial
population genetics is a discipline separate and
distinct from the study of the molecular epidemiol-
ogy of infectious agents. The research tools, meth-
ods of data analysis, and general thought
processes are very different from the typological
thinking used by investigators of disease out-
breaks or microbial pathogenesis (3-6).
Early work on the clonal nature of bacterial
pathogens was conducted largely with Escherichia
coli, through a framework supplied by serotyping
of one or a few polymorphic surface antigens (7, 8).
Only a few of the many possible O and H antigen
serotypes were frequently associated with out-
breaks of infantile diarrhea in the United
Kingdom and other countries, which suggested
that isolates expressing these traits had special
virulence properties (7-9). Because serotype
analysis of relatively few surface structures does
not provide robust data for estimating overall
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among strains, the primary research tool used to
examine the population genetics of emerging bac-
terial pathogens has been multilocus enzyme elec-
trophoresis (10, 11). This technique indexes allelic
variation in sets of randomly selected structural
genes located on the chromosome and provides a
basis for estimating overall levels of genotypic
variation in populations, i.e., the sample of bacte-
ria chosen for analysis. The key concept underly-
ing use of starch gel-based protein electrophoresis
in population genetics is that electromorphs (mo-
bility variants) of an enzyme can be directly
equated with alleles of the corresponding struc-
tural gene. Moreover, electromorph profiles over a
sample of different enzymes, therefore, correspond
to multilocus enzyme genotypes and are fre-
quently referred to as electrophoretic types or ETs.
The proteins analyzed are usually metabolic en-
zymes expressed by virtually all isolates of a spe-
cies under the growth conditions used. The allelic
variation detected is unaltered by environmental
conditions such as culture conditions, laboratory
storage, anatomic site of recovery, or specific clini-
cal disease. Allelic variation in these metabolic
enzymes is selectively neutral, or nearly so, which
means that convergence to the same allele through
adaptive evolution is unlikely (4, 12-14). As a con-
sequence, this approach to the study of bacterial
and other microbial
pathogens provides a
convenient strategy
for indexing overall
levels of chromosomal
diversity in the sample
and for inferring ge-
netic relationships
among strains. Be-
cause of the strong cor-
relation of chromo-
somal divergence in-
dexed by multilocus
enzyme electro-
phoretic data and
DNA-DNA hybridiza-
tion studies (15-18),
several cryptic species
have been identified
once their  existence
was initially discov-
ered by population ge-
netic analyses that
employed starch gel electrophoresis (16, 19-21). In
most bacterial species, the number of allelic vari-
ants is large, and it is unlikely that recombina-
tional processes would, by chance, frequently
generate strains with the identical electromorph
profile. Hence, organisms with the same electro-
morph profile are generally thought to be similar
by descent, rather than by convergence through
lateral gene flow.
Recently, convenient, rapid, and relatively inex-
pensive large-scale DNA sequencing techniques
have also been adopted by several laboratories.
Large-scale automated DNA sequencing has been
used to rapidly and unambiguously identify a
causative infectious agent and confirm or refute
the identity of isolates recovered from temporally-
linked patients thought to be involved in a disease
outbreak. In addition, sequence-based studies
have been employed to define the nature and
extent of allelic variation in toxin and other viru-
lence factor genes and to rapidly identify muta-
tions associated with antimicrobial agent
resistance (22).
Unless noted, data on the population genetic
analysis of emerging bacterial pathogens summa-
rized in this article were generated by multilocus
enzyme electrophoresis, sometimes performed in
concert with automated DNA sequencing.
Table 1. Representative Emerged Bacterial Pathogens Investigated with Molecular Population
Genetic Strategies
Organism Disease Reference
Borrelia species Lyme disease 146-149,150,151
Escherichia coli O157:H7 hemorrhagic colitis;
  hemolytic uremic syndrome 33-35
Haemophilus influenzae Invasive disease 156
H. influenzae
 biogroup  aegyptius Brazilian  purpuric  fever 25,26
Listeria monocytogenes Food-borne invasive disease 157, 158
Mycobacterium tuberculosis Tuberculosis 91,105
Neisseria meningitidis Sepsis, meningitis 52-63,66,69-73
Salmonella species Food-borne illness 159-161
Staphylococcus aureus Toxic shock syndrome;
 methicillin  resistant  strains 47,143,144
Streptococcus pyogenes Invasive disease,
 toxic-shock-like  syndrome 82,83,85
S.pneumoniae Otitis, pneumonia, sepsis,
 meningitis 125-131,136
Vibrio cholerae Cholera 153-155
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Brazilian Purpuric Fever
Brazilian purpuric fever (BPF), a serious inva-
sive disease of children, was first characterized in
1984 after an outbreak in Promissao, Sao Paulo
State, Brazil. Children with BPF have acute onset
of fever and usually die within 48 h with dissemi-
nated purpura, vascular collapse, and hypotensive
shock (23). BPF is caused by Haemophilus influ-
enzae biogroup aegyptius, an organism associated
with sporadic or epidemic conjunctivitis (24). Mul-
tilocus enzyme electrophoresis and other molecu-
lar techniques have demonstrated that isolates
recovered from BPF patients represent a distinct
clone (25).
As a first step toward identifying the evolution-
ary origin of this pathogenic H. influenzae bi-
ogroup aegyptius clone, chromosomal variation
and genetic relationships were indexed among 17
biogroup aegyptius isolates, and 2,209 encapsu-
lated H. influenzae strains were recovered world-
wide (26). Biogroup aegyptius isolates form three
distinct evolutionary lineages of the species H.
influenzae. Isolates of the case clone are only very
distantly related to other isolates classified as
biogroup aegyptius; that is, the case clone was no
more related to other biogroup aegyptius isolates
than are (for example) two H. influenzae isolates
selected at random from the species. The BPF case
clone was genetically allied with H. influenzae
isolates expressing serotype c polysaccharide cap-
sule, a result that explains an earlier observation
(27) that BPF isolates, like serotype c strains,
produce type 2 IgA1 protease, whereas other iso-
lates of biogroup aegyptius express type 1 IgA1
protease. Thus, the population genetic evidence
showed that biogroup aegyptius is polyphyletic
and that the BPF organism is a genetically distinct
clone unrelated to other isolates with the pheno-
typic criteria of biogroup aegyptius.
The genetic diversity in the sample of all bi-
ogroup aegyptius strains was approximately equal
to that recorded for entire species of certain patho-
genic bacteria (16, 17). Therefore, the effective
population size of aegyptius must be large; how-
ever, this interpretation is difficult to reconcile
with the observation that strains in the biogroup
are rare pathogens associated only with human
disease. A possible explanation for the relatively
extensive genetic diversity among biogroup aegyp-
tius strains is that they represent cell lineages
spawned from a much larger base population of
diverse nonpathogenic precursor clones. Accord-
ing to this hypothesis, acquisition or loss of one or
more genes (or, perhaps, a shift in ecological niche)
may produce a pathogenic form with the charac-
teristic viscerotropism for human conjunctivae.
Although population genetic analysis did not
provide a simple reason for the BPF outbreak, the
demonstration that the causative clone of bi-
ogroup aegyptius was highly differentiated from
other phenotypically similar organisms provided
an explanation for the unique infection manifesta-
tions and the unique group of characters associ-
ated with the clone (28-30). Moreover, population
genetic analyses demonstrated distinct medical
correlates to isolates classified as biogroup aegyp-
tius. The results of numerous subsequent studies
have confirmed that, as a population, H. influen-
zae biogroup aegyptius strains vary in their behav-
ior, as one would expect of a genetically diverse set
of organisms.
Escherichia coli O157:H7
Strains of E. coli expressing serotype O157:H7
were recognized in the early 1980s as important
causes of hemorrhagic colitis and hemolytic ure-
mic syndrome in North America (31). Disease usu-
ally occurs after consumption of contaminated
beef or other food. Several large outbreaks have
occurred, and more than 60 case clusters have
been reported in the United States (32). Because
several E. coli reference laboratories rarely iden-
tified organisms expressing this serotype before
the early 1980s, reporting of these isolates has
increased dramatically. Because of the medical
and economic importance of E. coli strains consid-
erable effort has been directed toward elucidating
genetic relationships among and between them as
well as between them and other members of the
species; as a result extensive information is now
available about clonal relationships among these
important bacteria (33-35).
The observation that O157:H7 strains synthe-
size one or more Shiga-like toxins and lack the
ability to rapidly ferment sorbitol initially sug-
gested that strains of this serotype had shared a
recent common ancestor. To directly test this idea,
multilocus enzyme electrophoresis was used to
assess genetic relatedness of 100 strains of E. coli
serotypes recovered from patients with hemor-
rhagic colitis or hemolytic uremic syndrome (33).
Although 25 distinct multilocus enzyme genotypes
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O157:H7 isolates are closely related organisms.
The results were interpreted to mean that
O157:H7 organisms recovered from epidemiologi-
cally unassociated North American outbreaks be-
long to a single geographically widespread
pathogenic clone with specific virulence properties
(33). Subsequent analysis of O157:H7 strains by
pulsed-field gel electrophoresis has supported this
idea (36).
To delineate clonal relationships among
O157:H7 organisms and other E. coli strains that
cause hemorrhagic colitis and infantile diarrhea,
1,300 isolates representing 16 serotypes from pa-
tients with these diseases were studied by multilo-
cus enzyme electrophoresis and probing for genes
encoding Shiga-like toxins (34). The O157:H7
clone was closely related to a clone of O55:H7
strains that has a long history of worldwide asso-
ciation with outbreaks of infantile diarrhea (34).
The data strongly suggested that the O157:H7 and
O55:H7 clones have recently radiated from a com-
mon ancestral cell. The O157:H7 clone arose from
an O55:H7-like ancestor, perhaps through hori-
zontal transfer and recombination events adding
Shiga-like toxin genes and adhesion genes to an E.
coli genome preadapted for causing diarrheal dis-
ease (34, 35). If, as the multilocus enzyme electro-
phoretic data indicate, O157:H7 and O55:H7
organisms have shared a recent common ancestor,
it is likely that the close genetic affiliation would
be reflected at the nucleotide level. To test this
notion, the gene (eae) (34) encoding intimin, a
protein involved in bacterial attachment to entero-
cytes and subsequent effacement of the microvilli,
was sequenced from representative isolates of
these two serotypes. The resulting sequence data
were consistent with the hypothesis that O157:H7
and O55:H7 organisms share a close genetic affin-
ity and thereby provide a plausible explanation for
the observation that these bacteria cause similar
attaching and effacing lesions in cells grown in
culture (38) and in animal models (39). Because
conventional serotyping of E. coli does not provide
a reliable basis for analyzing population structure
and can be grossly misleading as to genetic rela-
tionships among isolates (40-42), many important
medical correlates of the population structure will
not be recognized and understood fully until E. coli
isolates are sorted out along clonal lineages.
Staphylococcus aureus Toxic Shock Syndrome
Toxic shock syndrome (TSS) was described in
1978 (43) as a severe acute illness (characterized
by high fever, erythematous rash, hypotension or
shock, multiorgan involvement, and desquama-
tion of the skin) of young children associated with
infection with Staphylococcus aureus. Two years
later, it was recognized that TSS is a geographi-
cally widespread disease affecting mainly young,
healthy, menstruating women, especially those us-
ing certain high absorbency tampons (44). Most
vaginal isolates of S. aureus recovered from pa-
tients with TSS produce a chromosomally encoded
toxin, designated as toxic shock syndrome toxin-1
(TSST-1) (45). Evidence implicating TSST-1 as a
major virulence factor in the pathogenesis of TSS
has accumulated (46). Almost all strains recovered
from patients with menstrual TSS, which account
for approximately 90% of TSS cases, synthesize
TSST-1, whereas only 50%-60% of isolates from
cases of nonmenstrual TSS and 5%-25% of strains
causing other diseases produce this protein.
Several questions of importance to both medical
bacteriology and evolutionary genetics were ad-
dressed in a study of 315 TSST-1-producing
strains of S. aureus (47). It was discovered that the
organisms responsible for most cases of TSS with
a female urogenital focus are members of a single
distinctive clone (designated as ET 41), a result
that explains the observation that isolates recov-
ered from patients with TSS share many traits
(48, 49). The investigation also showed that TSST-
1 is expressed by isolates of a great variety of
clones representing virtually the full breadth of
genotypic diversity in the species as a whole. In
addition, isolates of ET 41 represented 24% of a
sample of TSST-1-producing strains recovered be-
fore 1978, which meant that the tst gene encoding
the toxin neither evolved nor was acquired re-
cently by this species. The failure to recover iso-
lates of ET 41 from non-human hosts effectively
eliminated the likelihood that animals are impor-
tant in the transmission of this clone.
Twenty-eight percent of isolates of S. aureus
cultured from the introitus, vagina, or cervix of
unassociated healthy carriers or women with non-
TSS urogenital symptoms were ET 41 or closely
allied clones; no other single multilocus enzyme
genotype accounted for more than 12% of normal
vaginal isolates. These observations led to the
hypothesis that isolates of ET 41 are more readily
able to colonize the human vagina and, hence, are
Perspective
Emerging Infectious Diseases 4 Vol. 2, No. 1 — January-March 1996widely dispersed in an ecological niche of great
consequence in TSS. Under this “adapted clone”
hypothesis, isolates of ET 41 are responsible for
most vaginal cases because this clone has a special
affinity for the cervicovaginal milieu, perhaps (but
not necessarily) as a consequence of variation in
regulation of toxin- or other virulence-gene expres-
sion. In summary, data derived from clonal analy-
sis of TSST-1-producing S. aureus are consistent
with the notion that the “bloom” in TSS cases
happened because of a change in the character of
catemenial products (perhaps associated with de-
creasing levels of anti-TSST-1 antibody in human
populations), not because of a new S. aureus
strain.
Two additional points are noteworthy regarding
population genetic analysis of S. aureus strains
producing TSST-1. First, if the gene encoding
TSST-1 were evolutionarily old, allelic variants
differing in nucleotide and, perhaps, amino acid
sequence would exist in natural populations. This
prediction was borne out by the identification of a
variant of TSST-1 associated with goat, sheep, and
occasionally bovine mastitis that is encoded by a
gene which differs from the “human” form by 14
nucleotides, resulting in 9 amino acid changes.
The variant toxin retains mitogenic activity for
mouse splenocytes but differs significantly in
other functions ascribed to TSST-1, including abil-
ity to induce a TSS-like disease in rabbits (50).
Second, if the rapid increase in TSS cases were
caused by a change in host character rather than
by the rapid spread of a single, new, hypervirulent
clone, subclonal heterogeneity would be present
among isolates classified as ET 41. Examination
of RFLP patterns for the gene (coa) encoding co-
agulase has shown at least three distinct sub-
clones of ET 41 (51).
Neisseria meningitidis
Extensive work in the last 10 years has exam-
ined the molecular population genetics of Neisse-
ria meningitidis, predominantly by clonal
analysis, and more recently by DNA sequencing of
putative virulence genes. This work suggests that
temporal variation in disease frequency and sever-
ity is usually associated with clonal replacement
much like influenza epidemics are driven by anti-
genic shift.
Serogroup B ET-5 Complex Organisms
Caugant et al. (52) demonstrated that an epi-
demic of serogroup B meningococcal disease that
began in the 1970s in Norway and subsequently
spread through much of Europe was caused by a
group of 22 very closely related clones, designated
as the ET-5 complex, that have no close genetic
relationship to other clone groups. Clones of this
complex were traced intercontinentally to Chile
and South Africa, where they also caused contem-
porary outbreaks of invasive disease. Clonal
analysis also showed that a severe epidemic of
meningococcal disease in Cuba (characterized by
a high attack rate and incidence of septicemia) was
due to ET-5 complex organisms. The recovery of
these same bacteria from outbreaks in Miami,
Florida, in 1980 and 1981, strongly suggested that
Cuban refugees imported the clones to Miami.
Members of the ET-5 complex have seldom been
recognized as important pathogens in the United
States. However, ET-5 complex organisms were
responsible for a recent increase in meningococcal
disease rates in Washington and Oregon (53). In
addition, a serogroup B epidemic in greater Sao
Paulo, Brazil, was also caused by ET-5 complex
members (54).
Recently, clonal analysis has been used to study
serogroup B meningococcal isolates that caused
invasive disease in The Netherlands between 1958
and 1986 (55). Significant temporal variation in
the clonal composition of meningococcal popula-
tions was identified. Recent disease episodes were
caused predominantly by isolates of three clonal
lineages (designated I, III, and VI) that were not
represented in samples collected before 1975. In
addition, an epidemic in 1966-1967, and a hyper-
endemic disease wave in 1972 were caused mainly
by two closely related clones (ET-11 and ET-17)
expressing serotype 2b protein. Strong statistical
deviation in the sex ratio was recorded for disease
caused by clones of two lineages. Clones of lineage
V were cultured far more frequently from female
than for male patients; whereas, clones of lineage
IX were recovered from disease in male patients
approximately four times more often than aver-
age. The cause(s) of these differences are unknown
but warrant further investigation.
For most bacterial pathogens, few data are
available regarding the frequency with which dis-
tinctive clones are recovered in asymptomatic per-
sons. Caugant et al. (56) studied the clonal
composition of meningococcal isolates cultured
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way and discovered that the frequency of recovery
of clones (ET-5 complex and ET-37 complex) caus-
ing 80% of disease episodes were represented by
only 7% and 9%, respectively, of carrier isolates.
This same study demonstrated that the clones
most commonly represented among carrier iso-
lates (19%) have never been recovered from pa-
tients with invasive meningococcal infection. The
data reinforce the concept that bacterial clones
vary dramatically in virulence potential.
Serogroup C Disease
An increase of invasive disease due to serogroup
C  N. meningitidis strains has been reported in
several countries in recent years (57-60). Study of
121 isolates recovered from patients in Greater
Sao Paulo, Brazil, between 1976 and 1990 identi-
fied a striking increase in isolates assigned to ET
11 complex (58). The percentage of invasive dis-
ease episodes caused by complex 11 organisms
increased from 8% in 1988 to 66% in 1990. Out-
breaks of serogroup C meningococci have also been
recently reported from distinct regions of the
United States (59) and Canada (57, 60). Analysis
of organisms collected from 13 U.S. outbreaks
identified five distinct multilocus enzyme types,
all very closely allied in overall chromosomal re-
latedness (59). Moreover, strains causing 4 of these
13 outbreaks were identical in multilocus enzyme
type (designated ET-15) to organisms responsible
for outbreaks in eastern Canada (60). Canadian
investigators have reported (60) that ET-15 organ-
isms had a significantly higher case-fatality ratio
than other invasive meningococcal disease iso-
lates, which may be due to a lower herd immunity
to the newly emerged clone.
Serogroup A  Disease
Unlike other serogroups of Neisseria meningi-
tidis, which are usually associated with endemic
disease, isolates expressing serogroup A capsular
polysaccharide are unusual in that they may cause
large epidemics. For example, serogroup A organ-
isms have been responsible for epidemics of inva-
sive disease in Africa, China, Iran, Greece,
Finland, Brazil, and Nepal (61). Major epidemics
every 5-10 years in the Sahel region of sub-Saha-
ran Africa have led to the description of a “menin-
gitis belt” and to detailed studies by clonal analysis
of the molecular epidemiology of serogroup A or-
ganisms responsible for these and other outbreaks
(62, 63).
A group led by M. Achtman assembled 423
serogroup A meningococcal isolates, recovered pri-
marily from invasive episodes, and representing
organisms responsible for 23 epidemics or out-
breaks between 1915 and 1983. Thirty-four dis-
tinctive clones were assigned to four complexes
representing groups of related clonal genotypes
(61). Most epidemics were caused by a single clone,
and the same clone often was responsible for con-
current epidemics in contiguous countries. For
example, serogroup A clone I-1 caused a pandemic
that began in North Africa and certain Mediterra-
nean countries in 1967 and spread throughout
West Africa in the subsequent 2 years; clone III-1
has been responsible for disease outbreaks in Fin-
land, Brazil, Nepal, and China.
Recently Achtman’s group has extensively char-
acterized more than 300 serogroup A isolates from
patients or carriers in one epidemic in The Gambia
in 1982-1983 and in 1984-1985 after an immuni-
zation program at the end of 1983. Analysis of a
representative subgroup of 64 isolates showed
that all were assigned to clone IV-1 (64, 65). Iso-
lates of this clone were examined for subclonal
variation with SDS-PAGE profiling, LPS profiling,
and genomic restriction endonuclease profiling,
and rare variants were detected. Two cell-surface
antigens (class 5 outer membrane protein and pili)
were unusually variable, and the hypothesis was
formulated that variation in the class 5 OMP
occurs as a consequence of recombinational events
affecting the translational reading frame. The
role, if any, of this subclonal microheterogeneity in
serogroup A meningococcal epidemics is being as-
sessed. Clonal analysis has provided a framework
that is being exploited to rationally select strains
for further characterization by molecular and se-
rologic techniques that may provide insight into
the forces driving a bacterial epidemic (66-68).
Clonal analysis also has demonstrated that se-
rogroup A isolates are a restricted phylogenetic
subpopulation of the species N. meningitidis (69).
This result may mean that the genotype bestowing
the epidemic phenotype has arisen a single time
and that it has not been successfully transferred
horizontally to unrelated phylogenetic lineages of
the species.
Moore et al. (70) employed clonal analysis to
document the intercontinental spread of an epi-
demic group A meningococcal clone complex by
Muslim hajis pilgrims in 1987. Apparently this
clone was carried from South Asia (Nepal and/or
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seminated in epidemic form to other hajis (pil-
grims) and to indigenous Saudis. The report of
invasive serogroup A meningococcal disease in
other Gulf nations and among hajis returning to
the United States, Europe (France and the United
Kingdom), and Africa (Ethiopia, Sudan, and Chad)
and the recovery of isolates of the same clone
complex (designated ET III-1) from persons in
these diverse geographic localities strongly sug-
gested that an unusually virulent organism had
been rapidly dispersed intercontinentally. Spread
of clone III-1 from Mecca to France by hajis was
independently confirmed by Riou et al. (71). This
meningococcal clone also caused recent episodes of
invasive disease in Sweden (72) and Kenya (73).
Streptococcus pyogenes Invasive Disease
Severe invasive infections caused by S. pyo-
genes have been reported with increased fre-
quency in recent years in the United States (74,
75), Europe (76-78), and elsewhere (79, 80). These
include both soft tissue infections, such as celluli-
tis, and deeper infections, including osteomyelitis,
necrotizing fasciitis, and sepsis, many of which
have occurred in previously healthy persons. The
observation that many patients have multiorgan
failure and other signs and symptoms mimicking
staphylococcal toxic shock syndrome led to the
characterization of a streptococcal “toxic-shock-
like syndrome” (TSLS) (81). Most S. pyogenes iso-
lates recovered from such patients produce one or
more pyrogenic exotoxins with significant amino
acid sequence homology and functional similarity
with several enterotoxins synthesized by S.
aureus (82).
To determine the genetic diversity and clonal
relationships among S. pyogenes isolates recov-
ered from patients with TSLS or other invasive
diseases in the United States, 108 organisms were
studied by multilocus enzyme electrophoresis and
analyzed for exotoxin A, B, and C synthesis (82).
The analysis showed that 33 distinctive clones
were present among isolates comprising the sam-
ple, but nearly half the disease episodes, including
more than two-thirds of the cases of TSLS, were
caused by strains of two related clones, designated
ET-1 and ET-2 (82). The production of pyrogenic
exotoxin A (scarlet fever toxin, which is bacterio-
phage-encoded), either alone or in combination
with other pyrogenic exotoxins, was associated
with recovery in patients with TSLS. This
association was present with isolates of the same
clone, as well as those of distantly related phylo-
genetic lineages. The data were interpreted as
strong circumstantial evidence that scarlet fever
toxin A itself, or, possibly, the product of a gene
tightly linked to it, is a factor in the pathogenesis
of TSLS.
Because an increase in disease caused by
strains expressing the M1 serotype protein had
also been observed in England, Sweden, Norway,
Germany, other European countries, and else-
where, we sought to determine if strains recovered
from these diverse localities were genetically al-
lied. Chromosomal diversity and relationships
among 126 M1 strains from 13 countries on five
continents were analyzed by multilocus enzyme
electrophoresis and restriction fragment profiling
by pulsed-field gel electrophoresis (83). All isolates
were also examined for the speA gene by PCR, and
to increase the possibility of identifying inter-
strain variation, strain subsets were examined by
automated DNA sequencing for allelic polymor-
phism in genes encoding M protein (emm), strep-
tococcal pyrogenic exotoxin A (speA),
streptokinase (ska), pyrogenic exotoxin B (speB),
and C5a peptidase (scp). Seven distinct emm1
alleles were identified that would express M pro-
teins differing at one or more amino acids in the
N-terminus variable region. Although substantial
levels of genetic diversity existed among M1 or-
ganisms, most invasive episodes were caused by
two subclones marked by distinctive multilocus
enzyme electrophoretic profile and PFGE restric-
tion fragment length polymorphism (RFLP) types.
One of these subclones (ET 1/RFLP pattern 1a)
has the speA gene, and was recovered worldwide.
Identity of speA, emm1, speB, and ska alleles in
virtually all isolates of ET 1/RFLP type 1a means
that these organisms have shared a common an-
cestor, and that global dispersion of this M1 sub-
clone has occurred very recently. The occurrence
of the same emm and ska allele in strains that are
well-differentiated in overall chromosomal char-
acter demonstrated that horizontal transfer and
recombination play a fundamental role in diversi-
fying natural populations of S. pyogenes.
The population genetic framework constructed
for S. pyogenes has been exploited to rationally
choose strains for comparative molecular charac-
terization of the gene (speA) encoding scarlet fever
toxin (84, 85). An analysis by Nelson et al. (84)
identified four alleles of speA in natural
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distinct clonal lineages and is, therefore, probably
evolutionarily old. The presence of identical exo-
toxin A structural genes in diverse phylogenetic
lineages means that the gene has been horizon-
tally distributed among clones, presumably by
bacteriophage-mediated transfer. Two other al-
leles (speA2 and speA3), characterized solely by
single nucleotide changes resulting in single
amino acid substitutions, were each identified in
single clones (ET 1 and ET 2) that together have
caused most of TSLS episodes. The restriction of
speA2 and speA3 to single clonal lineages can be
interpreted as evidence that these two alleles are
evolutionarily younger than speA1. A fourth allele
(speA4) also is present in a single phylogenetic
lineage and is 9% divergent from the other three
toxin alleles. The absence of synonymous (silent)
nucleotide changes in speA2 and speA3 is unusual
and suggests that the allelic variation is not selec-
tively neutral, which implies that the toxins are
not functionally equivalent. Moreover, the muta-
tions occur in a segment consisting of five amino
acids that are highly conserved in the aligned
sequences of staphylococcal enterotoxin A (SEA),
staphylococcal enterotoxin B (SEB), SEC1, SEC3,
SED, SEE, and streptococcal pyrogenic exotoxin C
(86). The segment of SPE A containing these vari-
ations is immediately adjacent to a region contain-
ing cysteine residues involved in the formation of
a disulfide loop believed to be required for mito-
genicity of SPE A and other bacterial superan-
tigens. Population genetic analysis then suggests
that there are functional correlates of the allelic
variation and that the alleles have been subject to
natural selection. Recent studies have shown that
the ability of the SPEA2 and SPEA3 variants to
stimulate human peripheral blood mononuclear
cells exceeds that of SPEA1 (87).
Mycobacterium tuberculosis
Perhaps no bacterial infection in recent years
has generated as much interest nationally as re-
surgent tuberculosis (TB) (88). Largely because of
the success of public health strategies, the inci-
dence of TB declined steadily in the United States
since the early 1950s, and the disease was thought
to be eradicable by the end of the first decade of
the 21st century (89). However, the yearly decline
in TB incidence ended in 1984, and after several
years of a plateau phase, resurged from 1988
through the present. An estimated 63,000 excess
cases occurred through 1993 (90). The HIV/AIDS
epidemic, immigration from countries with high
TB prevalence, and outbreaks in correctional in-
stitutions, nursing homes, shelters for the home-
less, and other congregative environments have
contributed to the resurgence (88). On a global
scale, one-third of the world’s population is in-
fected with this pathogen, and 8 million new TB
cases occur each year. Moreover, nearly 3 million
people die annually of TB, making it the leading
cause of death due to an infectious agent world-
wide (88). Hence, there is a need to understand the
nature and extent of molecular variation in this
pathogen.
Although the population genetics of M. tubercu-
losis has not been examined by multilocus enzyme
electrophoresis, a recent study (91) analyzed DNA
sequence diversity in eight loci (192,875 nucleo-
tides) from unassociated isolates recovered in
North America and Europe. The data showed al-
most a complete absence of coding sequence nu-
cleotide variation. To rule out the possibility that
restricted geographic sampling biased the data
set, 350-bp fragments of genes encoding the beta
subunit of RNA polymerase (rpoB), a 65-kilodalton
heat shock protein (hsp65), the A subunit of DNA
gyrase (gyrA), an enzyme involved in aromatic
amino acid biosynthesis (aroA), RecA protein
(recA), and a 1435-bp region of the gene (katG)
encoding a catalase-peroxidase enzyme important
in isoniazid resistance (92-94) and host-parasite
interactions (95), were sequenced from one ran-
domly selected isolate from each of seven countries
with well-differentiated human populations
(Switzerland, Turkey, Algeria, Somalia, Papua
New Guinea, Vietnam, and Tibet). A virtual lack
of nucleotide variation was also found in these
seven isolates, and sequencing of several genes
from many additional TB isolates has reinforced
the concept of extremely restricted structural gene
polymorphism. The paucity of sequence variation
was surprising for several reasons. First, paleo-
pathologic evidence suggests that humans got TB
as early as 3700 BC in Egypt and 2500-1500 BC
in Europe and also pre-Columbian North and
South America (96). Moreover, M. tuberculosis
DNA recovered from lung lesions in a 1000-year-
old Peruvian mummy confirmed that the disease
existed in the pre-Columbian New World (97).
Second, as noted above, there is a very large global
pool of infected persons (88), and third, consider-
able chromosomal restriction fragment length
polymorphism has been identified by probing with
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a population genetic interpretation of the data, it
was posited that M. tuberculosis may be only
15,000 to 20,000 years old, an age that dates
speciation and global dissemination to roughly the
same time as paleomigration into the New World.
The time frame is also consistent with speculation
(100) that the agent of human TB arose from the
very closely related cattle pathogen M. bovis by
host specialization occurring since the domestica-
tion of this animal some 8,000 - 10,000 years ago.
Recent large-scale DNA sequencing results are
also consistent with an interpretation that M.
tuberculosis and M. bovis have shared a recent
common ancestor.
These molecular population genetic findings
have considerable implications for M. tuberculosis
pathobiology research. First, the virtual absence
of naturally occurring nucleotide substitutions
greatly increases the likelihood that missense mu-
tations identified in genes associated with resis-
tance to antimicrobial agents actually confer
resistance rather than simply acting as conven-
ient surrogate markers of resistance (93, 94, 101,
102). Second, restricted allelic diversity means
that it is probable that only nominal amino acid
variation will occur in proteins of potential immu-
noprophylaxis, diagnostic, or virulence interest.
Clones W and Son of W
Commensurate with the rise of TB cases in the
United States was an increase in the number of
organisms resistant to one or more anti-TB medi-
cations (103). This trend has been viewed with
great concern by public health authorities and
clinicians, in part because no new first-line anti-
TB agents have been introduced in several dec-
ades. Certain communities have contributed
disproportionately to the documented increase is
resistant organisms, the most notable being New
York City (104), which has accounted for up to 60%
of all drug-resistant M. tuberculosis reported na-
tionally in some surveys. Although strains with
several antimicrobial agent susceptibility pat-
terns have been identified, approximately 300 or-
ganisms are invariably resistant to isoniazid,
streptomycin, rifampin, ethambutol, and variably
resistant to ethionamide, kanamycin, capreomy-
cin, and ciprofloxacin (105, 106). Early reports
based on IS6110 restriction fragment length poly-
morphism typing (99), other molecular techniques
(98, 107), and classic epidemiologic investigations
suggested that many of these organisms were
clonally related. More recent analysis using
IS6110 typing, several other molecular typing
strategies, and automated DNA sequencing to
identify the exact nucleotide changes responsible
for resistance to isoniazid, rifampin, and strepto-
mycin has unambiguously demonstrated the ex-
istence of two abundant closely related subclones
(arbitrarily named W and W1, son of W) that have
clearly shared a recent common origin (105). Mul-
tidrug resistance in these strains is due to sequen-
tial accumulation of amino acid substitutions
conferring resistance to each drug alone, rather
than a single-step molecular event, such as acqui-
sition of a multidrug-resistance-conferring plas-
mid. Progeny of these two subclones have now
spread well beyond the New York City borders.
The organisms have been isolated from patients
in other New York communities (108), Atlanta,
Miami, Denver, Las Vegas, and Paris, France
(109). Thus far, all patients documented to have
infection caused by W or W1 organisms can readily
be epidemiologically connected with New York
City, that is, secondary, tertiary, or quaternary
spread has not yet sufficiently obscured this im-
portant epidemiologic thread. Dissemination of
these difficult to treat W and W1 organisms
throughout New York City and other cities dem-
onstrates the devastating consequences of clonal
origin and spread of a bacterial pathogen. Because
some persons now infected latently with W and
W1 will later experience reactivation disease, dis-
semination of W and W1 has adverse implications
for TB control in the 21st century.
Penicillin-Resistant Streptococcus pneumoniae
The Gram-positive bacterial pathogen S. pneu-
moniae is a major cause of illness and death world-
wide (110, 112). In the United States, the organism
is responsible for more than 500,000 cases of pneu-
monia, 55,000 episodes of bacteremia, 6,000 cases
of meningitis, and 40,000 deaths each year (113).
Until relatively recently, antibiotic resistance in S.
pneumoniae was rare, but it is now a global public
health problem (114-116).
Resistance to penicillin in many organisms is
due to the expression of altered high molecular-
weight penicillin-binding proteins (PBPs) that
have reduced antibiotic affinity (117). Among re-
sistant strains, alterations in four (1A, 2X, 2A, and
2B) of the five high molecular-weight PBPs ex-
pressed by isolates of the species have been
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has shown that two processes have contributed to
the rise of these organisms. First, many distinct
susceptible strains are independently evolving to
the resistance phenotype. Acquisition of penicillin
binding protein gene segments from foreign do-
nors, such as oral streptococci, is apparently a
primary driving force (118). At the molecular level,
the result is generation of mosaic genes, and
thereby molecularly remodelled PBP proteins
with decreased affinity for penicillin (119-123).
Evidence shows that the Hex recombinational
pathway (124) participates. Once a distinct drug-
resistant cell has been generated, progeny can be
transmitted locally and over intercontinental dis-
tances by person-to-person spread (125-130). Mul-
tilocus enzyme electrophoresis has been applied to
analyze genetic relationships among penicillin-re-
sistant strains of S. pneumoniae from global
sources and to infer patterns of epidemiologic
spread of these resistant organisms (125-131).
The importance of rapid local clonal spread of
antibiotic-resistant S. pneumoniae is illustrated
by events in Iceland. Monitoring of antibiotic re-
sistance patterns of pneumococci in Iceland
showed no detectable penicillin-resistant organ-
isms in 1983 to 1988. The first penicillin-resistant
strain was recovered in December 1988 (132). The
frequency of penicillin-resistant organisms rose
sharply over the next 3 years from 2.3% to 17% of
all isolates in the first quarter of 1992 (132). Al-
most 70% of the resistant isolates expressed sero-
group 6 capsule polysaccharide and were also
resistant to tetracycline, chloramphenicol, eryth-
romycin, and trimethoprim-sulfamethoxazole. To
test the hypothesis that these Icelandic isolates
were clonally related, Soares et al. (128) examined
57 organisms for serotype, PBP pattern, pulsed-
field chromosomal restriction endonuclease diges-
tion pattern, and multilocus enzyme
electrophoretic genotype. All isolates were sero-
type 6B and had closely similar or identical pat-
terns for each of the molecular markers examined.
Surprisingly, the Icelandic organisms were indis-
tinguishable from a subgroup of multiresistant
serotype 6B pneumococci that occurs with high
incidence in Spain. The authors concluded that the
Spanish clone was imported to Iceland and noted
that in recent years a favored vacation locality for
Icelandic families with young children had been
Spain. The factors responsible for the precipitous
spread of the clone in Iceland are largely
unknown. The frequency of use of beta-lactam
antibiotics in Iceland and Sweden (a country
where resistant pneumococci are rare) in 1989 was
similar (133), and low compared to other industri-
alized countries (134). However, Iceland has a very
high use of antimicrobial agents such as trimetho-
prim-sulfamethoxazole, metronidazol, and tetra-
cycline (133, 134), which means it is conceivable
that selection for the multiresistant clone oc-
curred. A second possible factor contributing to the
clonal spread of the organisms is that 57% of
Iceland’s population of about 250,000 live in
Reykjavik and its suburbs, where most of these
strains have been recovered. Moreover, almost
80% of Icelandic children 2 to 6 years of age in
Reykjavik attend day-care centers. Together these
factors may have provided a unique set of circum-
stances for introduction and rapid spread of the
multiresistant clone.
Investigating the molecular population genet-
ics of pneumococci has led to the realization that
horizontal transfer and recombinational processes
are also serving to generate variation in capsule
type and immunoglobulin A1 (IgA1) protease gene
alleles (135, 136). Coffey et al. (135) analyzed
European resistant strains expressing serotype 9
or 19 through a combined approach employing
clonal analysis and RFLP profiling of genes encod-
ing PBP1A, PBP2B, and PBP2X. Analysis of a
resistant isolate synthesizing serotype 19 capsule
showed that it was identical in overall chromoso-
mal character to a clone of organisms resistant to
multiple antibiotics which expressed serotype
23F, a result that was interpreted as evidence that
horizontal transfer of capsular biosynthesis genes
had occurred. More recently, Lomholt (136) has
shown that recombinational processes contribute
to allelic variation in the gene (iga) encoding IgA1
protease.
Methicillin-Resistant Staphylococcus aureus
Very soon after methicillin entered clinical use
in the 1950s, strains of S. aureus resistant to this
antimicrobial agent were reported in the United
Kingdom (137). Within a few years, hospital out-
breaks caused by methicillin-resistant S. aureus
(MRSA) occurred in Europe. MRSA were recog-
nized as an important hospital infection control
problem in the United States in the mid-1970s,
and these organisms have now achieved global
distribution (138).
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expression of an altered penicillin-binding protein
(PBP) termed PBP 2a (139) that is encoded by the
chromosomal mec gene (140, 141). Evidence has
been presented that mec originated as a conse-
quence of a recombinational event fusing about
300 bp of a staphylococcal beta-lactamase gene
and a segment of a gene encoding a PBP from an
unknown donor bacterium, perhaps E. coli (142).
Multilocus enzyme electrophoresis and other
molecular population genetic techniques were
used to determine the extent of mec distribution
among phylogenetic lineages of the species and
genetic relationships among MRSA strains circu-
lating in various geographic regions at different
times (143, 144). The mec gene is harbored by
many divergent phylogenetic lineages repre-
senting a large portion of the breadth of chromo-
somal diversity in the species S. aureus. On the
basis of additional evidence, it was proposed that
multiple episodes of horizontal transfer and re-
combination have contributed to the spread of the
mec resistance determinant in natural popula-
tions. The identification of a single multilocus
enzyme genotype among MRSA organisms recov-
ered in the United Kingdom, Denmark, Switzer-
land, Egypt, and Uganda, soon after the
widespread introduction of methicillin into clini-
cal use in the 1960s, meant that MRSA isolates
recovered from those localities at that time were
progeny of a single ancestral cell that had probably
acquired the mec determinant recently. The mul-
tilocus enzyme electrophoretic data demonstrat-
ing association of mec with highly divergent
members of the S. aureus species effectively ruled
out the idea (145) that all extant MRSA are lineal
descendants of a single clone, and that mec was
acquired just once by methicillin-sensitive clones
of this pathogen.
Borrelia Species Associated with Lyme Disease
Molecular population genetic strategies have
also been used to delineate accurate phylogenetic
relationships among emerging organisms. For ex-
ample, Boerlin et al. (146) studied 50 isolates
classified as Borrelia burgdorferi by multilocus
enzyme electrophoresis and identified three dis-
tinct genetic clusters that were well differentiated
from one another in overall chromosomal charac-
ter. The investigators proposed that each cluster
represented a genospecies, and this idea was sub-
sequently supported by DNA-DNA reassociation
studies (147), 16S rRNA gene sequencing (148),
genomic fingerprinting by arbitrarily primed po-
lymerase chain reaction (149), and other
techniques (Valsangiacomo C, Balmelli T, Pif-
faretti J-C, pers. comm.). Moreover, different geno-
species of B. burgdorferi have been associated with
distinct clinical manifestations of Lyme borreliosis
(150-152).
Although population genetics has only been
applied to the study of pathogenic bacteria for
approximately a decade, considerable insight has
been gained into the molecular mechanisms of
temporal variation in disease frequency and sever-
ity, host adaptation of clonal lineages, and the
relationship of disease severity and naturally oc-
curring bacterial clones. The work cited in this
review represents only a small part of the contri-
bution of molecular population genetic investiga-
tions to an understanding of temporal variation in
disease frequency and severity, microbial patho-
genicity, and evolution of virulence genes. For
example, contributions have also been made from
studies of Vibrio cholerae (153-155), encapsulated
H. influenzae (156), L. monocytogenes (157-158),
Salmonella spp. (159-161), and other pathogens
(162).
Changes in human behavior, simple processes
of microbial evolution, and increasing resistance
to antimicrobial agents will continue to supply
mankind with new infectious disease challenges
and, therefore, motivation for molecular popula-
tion genetics studies. The genomes of two bacterial
pathogens have now been sequenced (163-164),
and it is likely that the genomes of most major
human and veterinary viral and bacterial patho-
gens will be sequenced in their entirety in the next
decade. Hence, the trend toward molecular dissec-
tion of microbial populations by large-scale DNA
sequencing will accelerate. DNA sequence-based
and conventional molecular population genetic
studies are cost-effective and should be encour-
aged in the fight to limit the detrimental impact
of infectious agents on human, animal, and plant
health.
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